Study aim: Assessing the effect of hot foot bath on controlling the symptoms of hospitalized patients with COVID-19 and accelerating the healing process Design: Randomized controlled clinical trial Settings and conduct: Sixty hospitalized patients with a positive nasopharyngeal PCR test or suspected

criteria: Study participation criteria: • All patients admitted with a diagnosis of COVID-19 • COVID-19

placebo. In this randomized study, phase 2/3 will be conducted on at least 8 patients with Covid-19. A

Study aim: Comparison of effect of Stress Management, Emotion Regulation, Eye Movement Desensitization and Reprocessing Therapy in Improving Resilience, Repetitive Negative Thoughts, Anxiety and Depression in Patients with Covid 19 Design: Clinical trial with parallel groups, not blinded, a sample of

Infliximab in the treatment of patients with Covid 19 Design: The study will be open label and random. Block (...) : Group 1: Patients with COVID-19 with inclusion criteria admitted to Firoozgar Hospital will be treated (...) treatment) and recommended treatments for COIVD-19. Group 2: patients will receive standard treatment with

quality of life, anxiety, depression and physical activity capacity in patients improved from Covid 19 (...) pulmonary embolism thrombosis; Acute symptoms of Covid 19 (temperature over 38 degrees ....); Systolic blood (...) the onset of symptoms in a patient with severe Quid 19. Exclusion criteria: unwillingness to

with Qovid-19 under treatment with oral Bromelain and Montelukast Design: This study was following (...) -19 accepted in the emergency department of Hospital. In this study, which is performed in phase 0 of the clinical trial, 60 patients with Quaid 19 accidentally (Based on client code number and patient

for SARS-CoV-19 virus or CT scan criteria) 2. The presence of symptoms indicates the severity of the

study Intervention groups: Treatment Group: Patients with coronavirus 19 who are transplanted with

on the perceived stress of family member of a patient with COVID-19 Design: Clinical trial with (...) patients have been hospitalized since the beginning of the COVID-19 outbreak. Participants/Inclusion and exclusion criteria: Patient Inclusion Criteria: - Patients with COVID-19 whose disease has been diagnosed by

Study aim: Determination of the effect of sofosbuvir/daclatasvir in COVID-19 patients Design: A clinical trial with a, with parallel control group, double-blind, randomized, phase 3, and multicenter (...) at any one time, Dry cough, Severe fatigue, Dyspnea, CT appearance compatible with COVID, O2Sat 94

-CoV-2, use of immunomodulators, tattoos on arms, participation in COVID-19 vaccine trials, Blood (...) Cohort 2) Main outcome variables: PCR-confirmed of Covid-19 between day 14 and 75 and day 14 and 90

Study aim: Effects of colchicine on persistent dyspnea and pulmonary fibrosis of COVID-19 patients after hospital discharge Design: 40 patients with history of persistent dyspnea after COVID19 infection (...) and/ or pulmonary fibrosis in COVID-19 patients at least 2 month after discharge from hospital and

. Participants/Inclusion and exclusion criteria: Inclusion criteria: Positive Covid-19 infection patients who are

Study aim: In this study, we tried to evaluate the possible effects of curcumin in the treatment of acute respiratory syndrome caused by coronavirus in patients treated with common drug regimens. Design: Clinical trial with control group, parallel groups trial, double-blind, phase 2-3 randomized on 42 patients and randomization using Excel software random function Settings and conduct: The study was performed on patients with acute respiratory syndrome of corona admitted to Golestan Hospital in Kermanshah. Participants/Inclusion and exclusion criteria: All patients admitted to the corona ward who test positive for PCR can be included in the study, and high-risk patients with underlying diseases or those in critical condition who require intensive care cannot be included in the study. Intervention groups: 1- The study group is the consumers of the usual drugs in addition to curcumin 2- The control group is the consumers of the usual drugs Main outcome variables: Body temprature; oxygen saturation; chest CT-scan

Study aim: Evaluation of therapeutic effect of licorice in the treatment of Covid 19 Design: 1 (...) diagnosed with mild covid . 2- informed consent will be obtained from all of them . It should be noted that (...) Intervention groups: 50 mild covid patients who will receive 300 mg licorice daily for one week Main outcome

Study aim: Comparing safety and serological response following homologous vs. heterologous COVID-19 (...) of the homologous COVID-19 vaccine versus the heterologous booster dose in 90 adult patients (...) , COVID-19 rapid test and antibody titer test will be performed, afterward, the national code enter into

Study aim: Determining the effect of chest expansion exercises on arterial blood oxygen saturation in hospitalized patients with covid-19 Design: Clinical trial with control group,with parallel (...) with a definite diagnosis of covid-19,Blood oxygen saturation level 75-90%,Age 25-55 years,Pulmonary

quality of COVID-19 recovered patients with sleep quality disorders in three areas: person, environment (...) least one month and at most three months have passed since COVID-19 was positive Based on the Mini (...) stresses such as recurrence of COVID-19 Intervention groups: 1. Intervention group: Sleep management

Study aim: Determining and comparing the therapeutic effects of intravenous vitamin C injection on laboratory findings in covid-19 patients Design: A clinical trial with a control placebo group; parallel (...) conduct: The study is a one-sided blind clinical intervention .Initially, 90 patients with covid-19 who

breastfeeding; Fever at the time of entry; Having an active infection with clinical signs of Covid-19; History of severe allergy to any type of vaccine; History of Guillain-Barré; Covid-19 vaccination at least 2 weeks before participation; receive Covid-19 vaccine for at least the next 2 weeks Intervention groups

infection with COVID-19 confirmed by PCR 2- Acute respiratory distress Syndrome of moderate to severe type

intervention) they are in. Participants/Inclusion and exclusion criteria: Inclusion Criteria: COVID-19

Study aim: The aim of this study is to determine the effect of nanocurcumin supplementation on serum level of hs-CRP, the severity of symptoms and length of hospital stay in patients with COVID-19 (...) COVID-19 (having a positive PCR test or involved lung CT-scan) who do not require ICU admission will be

on blood factors and clinical symptoms in patients with covid-19 Design: A clinical trial with a (...) intervention and placebo. Settings and conduct: The study is performed in hospitalized patients with covid-19 (...) /Inclusion and exclusion criteria: The status of entry: Patients should be exposed to covid-19. The